Siegfried Holding AG (SFZN):企業の財務・戦略的SWOT分析

◆英語タイトル:Siegfried Holding AG (SFZN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5003
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Siegfried Holding AG (SFZN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. Siegfried also offers development and production services for finished dosage forms including sterile filling. It serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Aargau Switzerland.

Siegfried Holding AG Key Recent Developments

Aug 21,2018: Siegfried reports higher sales and further improved margin for first half year
Jun 04,2018: Siegfried Group: Change in the Executive Committee
Mar 14,2018: Siegfried with Sales and Margin Growth
Aug 23,2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months
Mar 21,2017: Siegfried Group: Management Changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Siegfried Holding AG – Key Facts 6
Siegfried Holding AG – Key Employees 7
Siegfried Holding AG – Key Employee Biographies 8
Siegfried Holding AG – Major Products and Services 9
Siegfried Holding AG – History 10
Siegfried Holding AG – Company Statement 12
Siegfried Holding AG – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
Siegfried Holding AG – Business Description 17
Product Category: Drug Substances 17
Overview 17
Performance 17
Product Category: Drug Products 17
Overview 17
Performance 17
R&D Overview 17
Siegfried Holding AG – Corporate Strategy 18
Siegfried Holding AG – SWOT Analysis 19
SWOT Analysis – Overview 19
Siegfried Holding AG – Strengths 19
Siegfried Holding AG – Weaknesses 20
Siegfried Holding AG – Opportunities 21
Siegfried Holding AG – Threats 22
Siegfried Holding AG – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Siegfried Holding AG, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Aug 21, 2018: Siegfried reports higher sales and further improved margin for first half year 34
Jun 04, 2018: Siegfried Group: Change in the Executive Committee 36
Mar 14, 2018: Siegfried with Sales and Margin Growth 37
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months 38
Mar 21, 2017: Siegfried Group: Management Changes 39
Mar 14, 2017: Siegfried with Jump in Sales in 2016 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Siegfried Holding AG, Key Facts 6
Siegfried Holding AG, Key Employees 7
Siegfried Holding AG, Key Employee Biographies 8
Siegfried Holding AG, Major Products and Services 9
Siegfried Holding AG, History 10
Siegfried Holding AG, Subsidiaries 14
Siegfried Holding AG, Key Competitors 23
Siegfried Holding AG, Ratios based on current share price 24
Siegfried Holding AG, Annual Ratios 25
Siegfried Holding AG, Annual Ratios (Cont...1) 26
Siegfried Holding AG, Annual Ratios (Cont...2) 27
Siegfried Holding AG, Interim Ratios 29
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Siegfried Holding AG, Recent Deals Summary 33
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Siegfried Holding AG, Performance Chart (2013 - 2017) 28
Siegfried Holding AG, Ratio Charts 30
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Siegfried Holding AG (SFZN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Horizon National Corporation:企業の戦略・SWOT・財務情報
    First Horizon National Corporation - Strategy, SWOT and Corporate Finance Report Summary First Horizon National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • SteadyMed Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析
    Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • CardioDx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • BDO Unibank Inc:企業の戦略・SWOT・財務情報
    BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ilana Jivago Inc.:企業の戦略・SWOT・財務情報
    Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report Summary Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • InterContinental Hotels Group Plc:企業のM&A・事業提携・投資動向
    InterContinental Hotels Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's InterContinental Hotels Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Pioneer Energy Services Corp (PES):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Total E&P Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P Canada Ltd (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that offers exploration and production of oil and gas properties. The company has assets in Alberta’s Athabasca Oil Sands region, which include Surmont, Northern Lights, Fort Hills and Joslyn North …
  • Shire Plc (SHP):製薬・医療:M&Aディール及び事業提携情報
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to treat patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Elisa Oyj (ELISA):企業の財務・戦略的SWOT分析
    Elisa Oyj (ELISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Protege Energy III LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Protege Energy III LLC (Protege Energy) is an oil and gas exploration and production company. The company offers acquisition and development of oil and gas reserves including exploration, development, operations, horizontal drilling, reservoir stimulations, recompletions, artificial lift and …
  • Tiger Brands Ltd (TBS):企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Athabasca Oil Corp (ATH):企業の財務・戦略的SWOT分析
    Athabasca Oil Corp (ATH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lepanto Consolidated Mining Company:企業の戦略・SWOT・財務情報
    Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report Summary Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Volta River Authority:電力:M&Aディール及び事業提携情報
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. It produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. The authority procures energy from Takoradi International Company Ltd; an …
  • Yokogawa Electric Corporation:企業の戦略・SWOT・財務情報
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析
    Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting age …
  • Allied Technologies Limited:企業のM&A・事業提携・投資動向
    Allied Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆